Rodino-Klapac Louise bought SRPT
September 3, 2025 · Form 4 insider transaction
Rodino-Klapac Louise bought 93,875 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
93,875
Price
$0.00
Total value
N/A
InsiderRodino-Klapac Louise
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2025
Filing dateSeptember 5, 2025
Shares owned after178,612
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.; Includes 106 shares of common stock purchased on August 31, 2025 through the Company's Employee Stock Purchase Plan